Suppr超能文献

利用 C 降解基序 E3 KLHDC2 进行旁系同源特异性靶向蛋白降解的原理。

Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2.

机构信息

Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.

出版信息

Nat Commun. 2024 Oct 12;15(1):8829. doi: 10.1038/s41467-024-52966-3.

Abstract

PROTAC® (proteolysis-targeting chimera) molecules induce proximity between an E3 ligase and protein-of-interest (POI) to target the POI for ubiquitin-mediated degradation. Cooperative E3-PROTAC-POI complexes have potential to achieve neo-substrate selectivity beyond that established by POI binding to the ligand alone. Here, we extend the collection of ubiquitin ligases employable for cooperative ternary complex formation to include the C-degron E3 KLHDC2. Ligands were identified that engage the C-degron binding site in KLHDC2, subjected to structure-based improvement, and linked to JQ1 for BET-family neo-substrate recruitment. Consideration of the exit vector emanating from the ligand engaged in KLHDC2's U-shaped degron-binding pocket enabled generation of SJ46421, which drives formation of a remarkably cooperative, paralog-selective ternary complex with BRD3. Meanwhile, screening pro-drug variants enabled surmounting cell permeability limitations imposed by acidic moieties resembling the KLHDC2-binding C-degron. Selectivity for BRD3 compared to other BET-family members is further manifested in ubiquitylation in vitro, and prodrug version SJ46420-mediated degradation in cells. Selectivity is also achieved for the ubiquitin ligase, overcoming E3 auto-inhibition to engage KLHDC2, but not the related KLHDC1, KLHDC3, or KLHDC10 E3s. In sum, our study establishes neo-substrate-specific targeted protein degradation via KLHDC2, and provides a framework for developing selective PROTAC protein degraders employing C-degron E3 ligases.

摘要

PROTAC®(蛋白水解靶向嵌合体)分子诱导 E3 连接酶和靶蛋白(POI)之间的接近,以靶向 POI 进行泛素介导的降解。协同 E3-PROTAC-POI 复合物有可能实现新底物选择性,超越 POI 单独与配体结合所建立的选择性。在这里,我们将可用于协同三元复合物形成的泛素连接酶集合扩展到包括 C 降解基元 E3 KLHDC2。鉴定了与 KLHDC2 的 C 降解基元结合位点结合的配体,对其进行基于结构的改进,并与 JQ1 连接以招募 BET 家族新底物。考虑到从与 KLHDC2 的 U 形降解基元结合口袋结合的配体发出的出口向量,生成了 SJ46421,它与 BRD3 形成了非常协同的、平行选择性三元复合物。同时,筛选前药变体使克服了由类似于 KLHDC2 结合 C 降解基元的酸性部分引起的细胞通透性限制。与其他 BET 家族成员相比,对 BRD3 的选择性在体外泛素化和前药版本 SJ46420 介导的细胞降解中进一步表现出来。对 KLHDC2 的选择性也实现了对泛素连接酶的选择性,克服了 E3 自身抑制以结合 KLHDC2,但不结合相关的 KLHDC1、KLHDC3 或 KLHDC10 E3。总之,我们的研究通过 KLHDC2 建立了新底物特异性靶向蛋白降解,并为开发使用 C 降解基元 E3 连接酶的选择性 PROTAC 蛋白降解剂提供了框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5051/11470957/80210f245c2f/41467_2024_52966_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验